Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...
Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of ...
The United States Bankruptcy Court for the Southern District of New York (the "Bankruptcy Court") today indicated it will approve the Chapter 11 Plan of Reorganization (The "Plan") for Purdue Pharma L ...
A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7 ...
Purdue Pharma won bankruptcy court approval for an opioid-related settlement of at least $7.4 billion, clearing a path for ...
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...
A federal bankruptcy court judge Friday said he will approve OxyContin-maker Purdue Pharma's latest deal to settle thousands ...
A judge said Friday that he planned to approve a deal for OxyContin maker Purdue Pharma and members of the Sackler family who ...
NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...
Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities and individuals who say they were harmed by the company’s addictive ...
Purdue Pharma, which is owned by the Sackler family, manufactures and markets OxyContin -- one of the prescription ...
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, based on ...